
Sign up to save your podcasts
Or


Send us Fan Mail
Nick Jikomes talks to Jeff Ubersax, PhD, CEO of the biotechnology company Demetrix (who supported this episode). Jeff discussed the science behind how Demetrix is engineering baker's yeast to produce cannabinoids at an industrial scale, with a focus on making rare cannabinoids other than THC and CBD.
Jeff also discussed how he transitioned from academic science to running his own company, and offered advice for academic scientists in training who might be thinking about moving into biotechnology.
Episode Support: This episode was supported by Demetrix, a biotechnology company using cutting edge fermentation technology to produce rare cannabinoids that are safe, legal, and effective for health and wellness.
Support the show
Health Products by M&M Partners:
For all the ways you can support my efforts
By Nick Jikomes4.8
8181 ratings
Send us Fan Mail
Nick Jikomes talks to Jeff Ubersax, PhD, CEO of the biotechnology company Demetrix (who supported this episode). Jeff discussed the science behind how Demetrix is engineering baker's yeast to produce cannabinoids at an industrial scale, with a focus on making rare cannabinoids other than THC and CBD.
Jeff also discussed how he transitioned from academic science to running his own company, and offered advice for academic scientists in training who might be thinking about moving into biotechnology.
Episode Support: This episode was supported by Demetrix, a biotechnology company using cutting edge fermentation technology to produce rare cannabinoids that are safe, legal, and effective for health and wellness.
Support the show
Health Products by M&M Partners:
For all the ways you can support my efforts

5,007 Listeners

1,542 Listeners

1,926 Listeners

310 Listeners

1,272 Listeners

374 Listeners

5,372 Listeners

657 Listeners

29,272 Listeners

238 Listeners

188 Listeners

1,246 Listeners

113 Listeners

1,091 Listeners

75 Listeners